News
GlaxoSmithKline is fined record $3bn in US
Cite this as:
BMJ
2012;345:e4568
Related articles
Feature: Can Big Pharma put patients first?
Published 21 May 2013; BMJ 346 doi: 10.1136/bmj.f3285
Published 6 December 2012; BMJ 345 doi: 10.1136/bmj.e8324
Published 12 October 2012; BMJ 345 doi: 10.1136/bmj.e6909
Published 11 May 2012; BMJ 344 doi: 10.1136/bmj.e3343
See more
Published 26 April 2013; BMJ 346 doi: 10.1136/bmj.f2666
Published 18 April 2013; BMJ 346 doi: 10.1136/bmj.f2531
Published 7 February 2013; BMJ 346 doi: 10.1136/bmj.f826
Published 12 December 2012; BMJ 345 doi: 10.1136/bmj.e8437
Published 12 December 2012; BMJ 345 doi: 10.1136/bmj.e8405
This article has been cited by other articles:








Social bookmarking